HER-Vaxx(HER-2)
Official Title: A Phase 1b/2 Open-Label Study With Randomization in Phase 2 of IMU-131 HER2/Neu Peptide Vaccine Plus Standard of Care Chemotherapy in Patients With HER2/Neu Overexpressing Metastatic or Advanced Adenocarcinoma of the Stomach or Gastroesophageal Junction
Actual Study Start Date :August 30, 2017
Estimated Primary Completion Date :January 2022
Estimated Study Completion Date :February 2022
https://clinicaltrials.gov/ct2/show/study/NCT02795988?term=imugene&draw=2
Don't know if this has been posted already. Hopefully good results from phase 2 trials sometime this week or before the end of the month.
HER-Vaxx(HER-2)Official Title: A Phase 1b/2 Open-Label Study...
-
- There are more pages in this discussion • 22,362 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
0.003(5.77%) |
Mkt cap ! $404.2M | |||
| Open | High | Low | Value | Volume |
| 5.2¢ | 5.7¢ | 5.2¢ | $802.5K | 14.79M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 348447 | 5.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.5¢ | 1214875 | 6 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| IMU (ASX) Chart |